Risavarshni Thevakumaran 1,2, Adam Groh 3,4, Jo Anne Stratton3,4, and David Rudko 1,2,3
1Biological and Biomedical Engineering, McGill University, Montreal, QC, Canada, 2McConnell Brain Imaging Centre, Montreal, QC, Canada, 3Neurology and Neurosurgery, McGill University, Montreal, QC, Canada, 4Montreal Neurological Institute-Hospital, Montreal, QC, Canada
Synopsis
Quantitative
T2* and T1 relaxometry metrics calculated at 7T have high sensitivity to myelin
and can be jointly used to identify dirty-appearing white matter (DAWM) and normal-appearing
white matter (NAWM) pathology in post-mortem, multiple sclerosis (MS) brain
tissue. Relaxometry mapping was performed on fixed, cerebral brain samples from
MS patients and healthy donors. T2* and T1 distributions in WM from MS tissue exhibited bimodality and were shifted to higher relaxation time values
compared to healthy tissue. Using k-means clustering applied to 2D T2* and T1
MS tissue data, regions of DAWM were detected in periventricular WM for MS
tissue samples.
Introduction and Motivation
Multiple Sclerosis (MS) is a neurodegenerative disease
marked by inflammation, demyelination, neuronal loss and axonal degeneration.
The pathological features of MS manifest in white matter (WM) and gray matter
(GM) as both focal plaques and diffuse tissue injury, varying with MS phenotype,
disease duration and type of disease modifying therapy1.
Apparent transverse
relaxation time (T2*) and longitudinal relaxation time (T1)
are quantitative relaxometry metrics sensitive to myelin and iron in the brain.
T2* and T1 can be applied to assess the extent
and spatial distribution of diffuse WM pathology in MS2. Histopathological and imaging
studies of post-mortem MS brain tissue have revealed two distinct types of
diffuse non-plaque WM changes: normal-appearing WM (NAWM) and dirty-appearing
WM (DAWM). NAWM is characterized by demyelination, inflammation, axonal loss, and
lengthened T2* and T1 times3, 4. In contrast, DAWM shows greater
demyelination, greater increase in T2* and T1 times,
and typically comprises regions with indefinite boundaries3. However, the optimal quantitative
MRI method for unique discrimination of DAWM from NAWM and an understanding of the underlying MS pathological substrates is an ongoing area of
investigation.
The motivation for this
work was to apply high-resolution, robust 7T quantitative T2*
and T1 mapping of post-mortem MS brain tissue to identify and
discriminate NAWM and DAWM.Methods
Brain Samples:
Nine post-mortem, human cerebral brain sections were obtained from the Douglas-Bell
Canada Brain Bank (duration of formalin fixation ≥ 10 years). Specifically, 6
sections were obtained from two MS patient donors (Patient #1: Frontal, middle
and caudal large sections; Patient #2: Frontal small, frontal large and caudal
sections) and 3 sections were obtained from two healthy control donors (Control
#1: Frontal and caudal sections; Control #2: Caudal section).
MR Scanning:
Brain sections were scanned using a Siemens 7T Scanner (MAGNETOM Terra) with a 1Tx/32Rx
head coil (Nova Medical). Acquisitions included a slab-selective 3D Multi-Echo
(ME) GRE sequence (0.32mm3, TR = 46ms, TE = [6.84, 11.57, 16.30, 21.03,
25.76, 30.49]ms, FA = 15o, 25 averages) and a 3D MP2RAGE sequence (0.32x0.32x0.64mm3,
TR/TE = 3000/2.08ms, Turbo Factor = 24, echo spacing = 6.6ms, FA1/FA2 = 8/8o,
TI1/TI2 = 183/900ms, 25 averages). A 2.5mm3 B1+
map was acquired using Siemens’ Turbo-Flash B1+ mapping
protocol.
Data Processing:
For each 3D-MP2RAGE measurement, a T1 map was computed using Siemens’
MP2RAGE-based T1 fitting algorithm. Individual T1 maps and
ME-GRE magnitude images were averaged to yield high SNR TÂ1 maps and
ME-GRE images for each brain section. The averaged T1 data
was upsampled and registered to the ME-GRE data using FLIRT (FSL, v7.2). Based
on averaged ME-GRE magnitude data, T2* maps were computed
using a voxel-wise non-linear, least-squares fitting approach in MATLAB
(R2020b, Mathworks). To extract tissue-specific T1 and T2*
maps, the first echo image of the averaged ME-GRE was used to segment GM and WM,
via the ilastik Pixel Classification workflow5 (Figure 1). Next, normalized, smoothed T1
and T2* distributions in WM were generated from the MS patient
and healthy control experimental groups (Figure 2). The distributions were fitted with bimodal and unimodal Gaussian
functions to extract unique peak positions (Figure 3). Given the bimodal T2* and T1
distributions for the MS patient group, the first (lower) and second (higher)
modes were assumed to arise from the presence of NAWM and DAWM respectively. This
assumption was made since DAWM is expected to entail a greater increase in T2*
and T1 compared to NAWM. To that end, “NAWM” here refers to all non-plaque
WM outside the region classified as DAWM.
Classification:
K-means clustering (k = 2) was applied to the MS tissue T1 and T2*
2D data to create a classifier capable of discriminating between apparent NAWM
and DAWM. For each brain section, a bivariate histogram of T2*
versus T1 was plotted (Figure 4)
and clusters of T2*-T1 values representative
of DAWM (blue) and NAWM (pink) were indicated. A mask showing the spatial
distribution of DAWM was also generated (Figure 5). Results and Discussion
T2*
and T1 distributions in the MS patient group were lower in peak
height, broader and shifted to longer relaxation time values compared to those of the healthy control
group (Figure 3E).
The broader distributions suggest heterogeneity of non-plaque abnormal WM6. The difference
in NAWM and DAWM T1 and T2* peak positions reflects
the impact of myelin phospholipid damage3 on DAWM.
Bivariate T2*-T1 relative frequency histograms
(Figure 4) revealed two distinct hyperintensities in MS tissue which were not
present in control tissue. The hyperintensities were demarcated by a linear
decision boundary (approximately T1 = 289 ms) calculated with
K-means clustering. Mean (T1, T2*) positions for the k-means clusters
representative of NAWM and DAWM were (250, 26.7)ms and (325, 36.1)ms
respectively.
The DAWM regions detected by the K-means classifier were
located in periventricular WM (Figure 5), consistent with results of MS
histopathological studies3. In most MS sections (A, B, F), DAWM did not have
ill-defined borders but, rather, was well-delineated, comprising nearly half
the tissue slab area. These findings support the joint use of 7 T T2*
and T1-based relaxometry approaches for
identifying NAWM and DAWM pathology in MS. More definitive support based on ex-vivo
histological myelin staining is underway, as a topic of our future work. Acknowledgements
We gratefully acknowledge the Douglas-Bell Canada Brain Bank as the source of formalin fixed cerebral human brain tissue used in our work. References
1. Lassmann H, van Horssen J Fau -
Mahad D, Mahad D. Progressive multiple sclerosis: pathology and pathogenesis.
(1759-4766 (Electronic)).
2. Stüber C, Morawski M, Schäfer A, et
al. Myelin and iron concentration in the human brain: a quantitative study of
MRI contrast. Neuroimage.
2014;93 Pt 1:95-106.
3. Moore
GR, Laule C, Mackay A, et al. Dirty-appearing white
matter in multiple sclerosis: preliminary observations of myelin phospholipid
and axonal loss. J Neurol. 2008;255(11):1802-1811.
4. Bagnato F, Hametner S, Yao B, et al.
Tracking iron in multiple sclerosis: a combined imaging and histopathological
study at 7 Tesla. Brain. 2011;134(12):3602-3615.
5. Berg S, Kutra D, Kroeger T, et al.
ilastik: interactive machine learning for (bio)image analysis. Nature Methods.
2019;16(12):1226-1232.
6. Vrenken H, Geurts JJ, Knol DL, et al. Whole-brain T1
mapping in multiple sclerosis: global changes of normal-appearing gray and
white matter. Radiology. 2006;240(3):811-820.